期刊名称：TRANSLATIONAL CANCER RESEARCH ISSN： 2218-676X 出版频率： Bi-monthly 出版社： AME PUBL CO, FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, PEOPLES R CHINA, HONG KONG, 00000   出版社网址： http://www.thestm.org/ 期刊网址： http://www.thetcr.org/ 影响因子： 1.241 主题范畴： ONCOLOGY;    China Journals 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Print ISSN: 2218-676X; Online ISSN 2219-6803 Translational Cancer Research Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; www.thetcr.org) is an Open Access, peer-reviewed journal, published by AME Publishing Company, publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. TCR will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving cancer patients' lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.  ➢ Manuscripts Turnaround Time: In-house review: 3-5 days External peer review: 1 month Revision time: 2-4 weeks Publication Ahead of Print: within 1 month after being accepted Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority. ➢ The Official Publication of: Society for Translational Medicine (STM), Hong Kong Published by AME Publishing Company Address: Room 604 6/F Hollywood Center, 77-91 Queen's road, Sheung Wan, HongKong Phone: +86 20 66355775 Fax: +852 3188 5078 Email: tcr@amepc.org   Instructions to Authors Submit Multimedia Files Submit your multimedia files directly to our editorial office in one simple step. For fast uploads please attach your file(s) as compressed .zip or .sit files. Once upload has been initiated, do not close the window until you have received on screen confirmation that your upload has been successful. Please note that the maximum size of each file has a limit of 2GB. If your file(s) for submission are greater than this limit, please divide the file into multiple segments, with the file names labelled in the correct order. Contact us: tcr@amepc.org Please submit the file(s) via: www.wetransfer.com. Instructions to Authors tcr-instruction-for-authors.pdf Editorial Board Editor-in-Chief: Eric Y Chuang, Sc.D Eric Chuang received his doctorate in cancer biology with toxicology and molecular genetics as two sub-specialties from Harvard University and his doctoral thesis was to study radiation-induced mutagenesis in human cells. After graduation, he stayed at Harvard as a postdoctoral fellow for one year. He then joined the NCI Radiation Biology Branch as an IRTA fellow to study Radiogenomics in Bethesda, MD. Next, he became the Head of Microarray Laboratory for Radiation Oncology Sciences Program at NCI; his lab was to develop new initiatives that utilized state-of-the-art microarray technologies for studying radiation oncology related research projects. Being an expert in microarray technologies and radiation biology/oncology, he has published more than 40 peer reviewed papers in related fields. After working at the NIH for several years, he took a faculty position at National Taiwan University (NTU). In 2009, he joined the Radiation Research Program of Division of Cancer Treatment and Diagnosis as a Program Director to oversee a portfolio of grants that include radiation-induced signaling pathways, molecular mechanisms and normal tissue injuries as well as radiation related genomic studies. In 2011, he returned to National Taiwan University and is currently a Professor and Director of NTU-Yonglin Biomedical Engineering Center.   Editorial Team Editor-in-Chief Eric Y Chuang, Sc.D Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University. Taipei, Taiwan Co-Editor-in-Chief Huan Giap, MD, PhD Scripps Proton Therapy Center, Chief of GI, Lung, and Breast Services, Director of Clinical Research, San Diego, CA 92121, USA Associate Editor-in-Chief Binghe Xu, Prof., MD, PhD Department of Medical Oncology at the Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS), and Peking Union Medical College (PUMC) in Beijing, China Editorial Board Mansoor M. Ahmed, PhD Radiotherapy Development Branch (RDB), Radiation Research Program (RRP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute/National Institutes of Health, 9609 Medical Center Drive, Rm. 3W224, Rockville, USA Lyudmila Bazhenova, MD Division of Hematology-Oncology, University of California San Diego, Moores Cancer Center, CA, USA Stefan Both, PhD Department of Radiation Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, USA Alejandro Carabe-Fernandez, PhD Dept. of Radiation Oncology, The Hospital of the University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA19104 USA Andrew L. Chang, MD Pediatrics, Scripps Proton Therapy Center, San Diego, CA; Hampton University Proton Therapy Institute; ProCure Proton Treatment Centers, USA Dr. King-Jen Chang, MD, PhD Department of Surgery, Cheng Ching General Hospital, Taichung 407, Taiwan   Benjamin Ping-Chi Chen, PhD Department of Radiation Oncology and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX75390, USA David J. Chen, PhD Division of Molecular Radiation Biology, Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA Dung-Tsa Chen Biostatistics Department, Moffitt Cancer Center & Research Institute, Tampa, USA Yidong Chen, PhD Department of Epidemiology and Biostatistics, The University of Texas, Health Science Center at San Antonio, San Antonio, TX, USA. Gary A Clawson, PhD, MD Gittlen Cancer Research Foundation, and the Departments of Pathology & Biochemistry and Molecular Biology, Hershey Medical Center, Pennsylvania State University, Hershey, USA. F. Avraham Dilmanian, PhD Departments of Radiation Oncology and Neurology, State University of New York (SUNY) at Stony Brook, Health Sciences Center, NY 11794-7028, USA Jian-Bing Fan Senior Director of Scientific Research, Illumina, Inc. Catherine T. Frenette, MD Department of Organ Transplantation, Scripps Green Hospital, San Diego, California, USA Giusi Irma Forte, PhD Institute of Molecular Bioimaging and Physiology (IBFM), Cefalù Support Unit (U.O.S), National Research Council (CNR) – Laboratory of Oncologic Technologies (LATO), Cefalù, Italy David Gius, MD, PhD Robert H. Lurie Comprehensive Cancer Center, Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA David Grosshans, MD, PhD Department of Radiation Oncology, U.T. MD Anderson Cancer Center, Houston, TX, USA Ryan S. Grover Scripps Proton Therapy Center, San Diego, CA; Department of Radiation Medicine, Loma Linda University School of Medicine, Loma Linda, CA Jona Hattangadi-Gluth, MD Department of Radiation Oncology, University of California San Diego, San Diego, California, USA Tom K. Hei, PhD Center for Radiological Research, College of Physicians and Surgeons, Columbia University, NY, USA. Sunil Krishnan, MD, FACP Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA Andrew S. Kennedy, MD, FACRO, Physician in Chief Radiation Oncology, Sarah Cannon Research Institute, Nashville, Tennessee, USA Kazushi Kishi, MD, PhD President of Hokuto Institute Hospital, General manager of Department of Radiation Oncology, Hokuto Hospital, Obihiro City, Hokkaido, Japan Jang-Ming Lee, MD, PhD Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. Richard P. Levy International Conference on the Application of Accelerators in Research and Industry (CAARI), Fort Worth, TX Chuan-Yuan Li, PhD Department of Dermatology, Duke University Medical Center, Durham, NC, USA Steven K. Libutti, MD, FACS, Director Montefiore-Einstein Center for Cancer Care The Marvin L. Gliedman, NY, USA. Charles Limoli, PhD, Professor Department of Radiation Oncology, University of California, Irvine, CA, USA Gina J. Mansy, MD Radiation Oncology, South Bay, University of California San Diego, Chula Vista, CA, USA Franco M. Muggia, MD Professor of Medicine, New York University School of Medicine, USA. Kevin T. Murphy, MD Department of Radiation Medicine and Applied Sciences, University of California, San Diego, USA Romaine C. Nichols, M.D. Associate Professor, Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA Rao V. L. Papineni Adjunct Faculty, University of Kansas Medical Center, USA Pataje G.S. Prasanna, PhD, Program Director National Cancer Institute, DCTD, RRP, Bethesda, MD, USA. Ajay Pal Singh Sandhu, M.D., D.M.R.T. Department of Radiation Oncology, University of California San Diego, Moores UCSD Cancer Center, CA, USA Reinhard W. Schulte, MD, MS, DABR Division of Radiation Research, Department of Basic Sciences, Loma Linda University, Loma Linda, CA 92354, USA Wolfgang A. Schulz, PhD Department of Urology, University Hospital and Medical Faculty of the Heinrich-Heine University Düsseldorf, Universitätsstr, Germany Fareeha Siddiqui, MD The University of San Diego Cancer Center, San Diego, USA. Koji Tsuboi MD, PhD Proton Medical Research Center , Faculty of Medicine, University of Tsukuba, Ibaraki, Japan. Sandra Vermeulen, MD Swedish Radiosurgery Center, Swedish Medical Center, Seattel, Washington, USA Daniel Vicario, MD Medical Director, San Diego Cancer Center, San Diego, California, USA Chia-Lin Wei, Ph.D Director, Genome Technologies at The Jackson Laboratory, CT USA Frederik Wenz, MD Department of Radiation Oncology, University Medical Centre Mannheim, University of Heidelberg; Interdisciplinary Cancer Center, University Medical Center Mannheim Marin Feldman Xavier, MD Cancer Research, Scripps Mercy Hospital, San Diego, USA Heng Xie, MD, PhD, MPH Medical Officer / Program Director, Clinical Grants and Contracts Branch, Cancer Therapy Evaluation Program, National Cancer Institute Zhi-Min Yuan, MD, PhD Department of Genetics and Complex Diseases, Harvard University School of Public Health, Boston MA. Daohong Zhou, MD Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Senior Editors Nancy Q. Zhong Editorial Office, Translational Cancer Research Grace S. Li Editorial Office, Translational Cancer Research Eunice X. Xu Editorial Office, Translational Cancer Research Elva S. Zheng Editorial Office, Translational Cancer Research Science Editors Molly J. Wang Editorial Office, Translational Cancer Research Melanie C. He Editorial Office, Translational Cancer Research Lucille L. Ye Editorial Office, Translational Cancer Research